Adaptive Trial Design for Phase 1 Dose-Finding Studies
Greater flexibility, efficiency and quicker dissemination of research findings to patient communities that stand to…
Certara2024年6月7日
From Concept to Market: Value of MIFD & Simcyp Biopharmaceutics for Streamlined Drug Formulation and Approvals
Free Webinar for Biopharmaceutics and Drug Formulation Scientists Join us for an insightful discussion with…
Certara2024年6月4日
Requirements for Efficient PK Analysis: Repository to Report
データの集約は、ファーマコメトリクス・ワークフローの最初のステップです。For teams conducting thousands…
Certara2024年5月30日
Target mediated drug disposition – a population PKPD analysis of literature data
Drs. Gabrielsson and Wendt will continue to co-present a new case study about analyzing acute…
Certara2024年5月30日
Clinical Pharmacology & Model-Informed Drug Development Insights for Targeted Radiation Therapies
標的放射線治療（TRT）は、腫瘍に対して選択的に細胞毒性のある放射線を届けます。In recent years, oncology drug…
Certara2024年5月22日
Unlocking Efficiency in Formulation Development and Approvals with MIFD & Simcyp Biopharmaceutics [APAC Webinar]
Biopharmaceutical professionals can gain a significant edge in formulation development by attending this free webinar…
Certara2024年5月16日
RAPS Sponsored Webcast: Regulatory & Tech Advances in Drug Safety Reporting
Meeting the escalating global demand for new medications requires expediting regulatory submission development. Documenting drug…
Certara2024年5月3日
The Neuroplatform: Towards a Comprehensive Mechanistic QSP Model of Alzheimer’s Disease for Supporting Drug Discovery and Development
With over 55 million people diagnosed worldwide, Alzheimer's disease presents a significant public health challenge,…
Certara2024年4月29日
Exploring ADC pharmacokinetics using QSP
The Pharmacokinetics (PK) of ADC therapeutics typically show a discrepancy between the PK of total…
Certara2024年4月12日
